Table 4. Multivariate analysis of predictors for short TTR.
| Location | Colon cancer | Rectal cancer | ||||||
|---|---|---|---|---|---|---|---|---|
| Stage | Stage II | Stage III | Stage II | Stage III | ||||
| Factors | HR CI |
P | HR CI |
P | HR CI |
P | HR CI |
P |
| Gender: Male | 0.73 0.53-1.02 |
NS | ||||||
| CEA: High | 1.47 1.06-2.03 |
0.02 | 1.34 1.04-1.73 |
0.02 | ||||
| Nodal status: N2 | 1.23 0.92-1.64 |
NS | ||||||
| Lymphatic invasion | ||||||||
| ly2/3 | 1.83 1.03-3.05 |
0.04 | ||||||
| ly3 | 1.73 1.09-2.64 |
0.02 | 1.5 0.86-2.45 |
NS | ||||
| Venous invasion | ||||||||
| v2/3 | 1.42 1.07-1.88 |
0.01 | ||||||
| v3 | 1.63 1.09-2.36 |
0.02 | ||||||
| Type of recurrence: | ||||||||
| M1b | 1.25 0.88-1.74 |
NS | ||||||
| Recurrence sites | ||||||||
| Liver (+) | 1.44 0.99-2.09 |
NS | 1.92 1.41-2.61 |
<0.0001 | ||||
| Distant LN: (+) | 1.53 0.84-2.61 |
NS | 0.52 0.23-1.03 |
NS | ||||
CEA: Carcinoembryonic antigen, CI: confidence interval, HR: hazard ratio, LN: lymph node, NS: Not significant, TTR: time to recurrence.